# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 166: Amendment of regulation 205 (obligations on holders in relation to public announcements)

Extent: E+W+S+N.I.

(1) Regulation 205 is amended as follows.
(2) In paragraph (2), after “bodies listed in paragraph (3)” insert “where the product is subject to a UKMA(NI), UKMA(UK), THR(NI), THR(UK) or Article 126a authorisation, or the licensing authority where the product is subject to a UKMA(GB) or THR(GB),”
(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/166 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-166
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.